1. Home
  2. ACET vs CVGI Comparison

ACET vs CVGI Comparison

Compare ACET & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • CVGI
  • Stock Information
  • Founded
  • ACET 1947
  • CVGI 2000
  • Country
  • ACET United States
  • CVGI United States
  • Employees
  • ACET N/A
  • CVGI N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • CVGI Auto Parts:O.E.M.
  • Sector
  • ACET Health Care
  • CVGI Consumer Discretionary
  • Exchange
  • ACET Nasdaq
  • CVGI Nasdaq
  • Market Cap
  • ACET 70.3M
  • CVGI 71.8M
  • IPO Year
  • ACET N/A
  • CVGI 2004
  • Fundamental
  • Price
  • ACET $0.67
  • CVGI $1.15
  • Analyst Decision
  • ACET Buy
  • CVGI Buy
  • Analyst Count
  • ACET 6
  • CVGI 1
  • Target Price
  • ACET $6.00
  • CVGI $10.00
  • AVG Volume (30 Days)
  • ACET 312.0K
  • CVGI 413.3K
  • Earning Date
  • ACET 03-06-2025
  • CVGI 05-05-2025
  • Dividend Yield
  • ACET N/A
  • CVGI N/A
  • EPS Growth
  • ACET N/A
  • CVGI N/A
  • EPS
  • ACET N/A
  • CVGI N/A
  • Revenue
  • ACET N/A
  • CVGI $723,355,000.00
  • Revenue This Year
  • ACET N/A
  • CVGI N/A
  • Revenue Next Year
  • ACET N/A
  • CVGI $6.33
  • P/E Ratio
  • ACET N/A
  • CVGI N/A
  • Revenue Growth
  • ACET N/A
  • CVGI N/A
  • 52 Week Low
  • ACET $0.67
  • CVGI $1.11
  • 52 Week High
  • ACET $2.40
  • CVGI $6.64
  • Technical
  • Relative Strength Index (RSI)
  • ACET 32.94
  • CVGI 27.53
  • Support Level
  • ACET $0.74
  • CVGI $1.11
  • Resistance Level
  • ACET $0.91
  • CVGI $1.29
  • Average True Range (ATR)
  • ACET 0.06
  • CVGI 0.10
  • MACD
  • ACET -0.01
  • CVGI -0.02
  • Stochastic Oscillator
  • ACET 0.36
  • CVGI 7.84

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a supplier of cab-related products and systems. Its operating segments are Vehicle Solutions, Industrial Automation, Electrical Systems, and Aftermarket and Accessories. Vehicle Solutions segment designs manufacture and sell Commercial vehicle seats and Plastic components. Warehouse Automation segment designs, manufactures, and sells Warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. Electrical Systems segment designs, manufactures and sells cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies, and design and engineering for these applications. The company makes majority of its revenue from Vehicle Solutions.

Share on Social Networks: